Total Payments
$279,386
2024 Payments
$38,659
Companies
39
Transactions
685
Medicare Patients
8,560
Medicare Billing
$575,745
Payment Breakdown by Category
Other$230,246 (82.4%)
Travel$24,408 (8.7%)
Food & Beverage$14,075 (5.0%)
Consulting$7,466 (2.7%)
Education$3,191 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $230,246 | 94 | 82.4% |
| Travel and Lodging | $24,408 | 36 | 8.7% |
| Food and Beverage | $14,075 | 531 | 5.0% |
| Consulting Fee | $7,466 | 9 | 2.7% |
| Education | $3,191 | 15 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $224,246 | 223 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $23,968 | 53 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $9,331 | 11 | $0 (2019) |
| INTUITIVE SURGICAL, INC. | $6,368 | 20 | $0 (2024) |
| Covidien LP | $4,806 | 8 | $0 (2020) |
| Boston Scientific Corporation | $1,734 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,568 | 62 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,421 | 139 | $0 (2024) |
| Pulmonx Corporation | $1,313 | 5 | $0 (2023) |
| United Therapeutics Corporation | $1,062 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,659 | 122 | Actelion Pharmaceuticals US, Inc. ($23,416) |
| 2023 | $14,300 | 101 | Boehringer Ingelheim Pharmaceuticals, Inc. ($11,835) |
| 2022 | $18,021 | 93 | Boehringer Ingelheim Pharmaceuticals, Inc. ($16,115) |
| 2021 | $18,008 | 77 | Boehringer Ingelheim Pharmaceuticals, Inc. ($17,182) |
| 2020 | $13,306 | 54 | Boehringer Ingelheim Pharmaceuticals, Inc. ($12,875) |
| 2019 | $62,016 | 82 | Boehringer Ingelheim Pharmaceuticals, Inc. ($59,873) |
| 2018 | $75,142 | 103 | Boehringer Ingelheim Pharmaceuticals, Inc. ($65,614) |
| 2017 | $39,933 | 53 | Boehringer Ingelheim Pharmaceuticals, Inc. ($32,924) |
All Payment Transactions
685 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: Cardiology | ||||||
| 12/23/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: Cardiology | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $5.37 | General |
| Category: HFCWO | ||||||
| 12/13/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.79 | General |
| Category: HFCWO | ||||||
| 12/12/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $8.09 | General |
| Category: HFCWO | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $32.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| Category: Medical Device | ||||||
| 12/02/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: Cardiology | ||||||
| 12/02/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $2.30 | General |
| Category: Cardiology | ||||||
| 11/23/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $66.77 | General |
| Category: HFCWO | ||||||
| 11/22/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $94.95 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,770.00 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $20.70 | General |
| Category: HFCWO | ||||||
| 11/01/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $54.30 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,270.00 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,354 | 2,498 | $736,070 | $148,312 |
| 2022 | 25 | 2,142 | 2,239 | $563,679 | $132,457 |
| 2021 | 27 | 2,157 | 2,268 | $664,975 | $162,495 |
| 2020 | 28 | 1,907 | 2,031 | $522,932 | $132,482 |
Total Patients
8,560
Total Services
9,036
Medicare Billing
$575,745
Procedure Codes
123
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 174 | $64,032 | $16,658 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 106 | 115 | $59,225 | $14,014 | 23.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 319 | 336 | $55,104 | $13,932 | 25.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 316 | 332 | $52,124 | $13,484 | 25.9% |
| 31641 | Destruction of growth or narrowing of lung airway using an endoscope | Facility | 2023 | 50 | 68 | $56,166 | $13,325 | 23.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 64 | 64 | $40,448 | $10,415 | 25.7% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 42 | 43 | $26,832 | $5,772 | 21.5% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 44 | 44 | $30,863 | $5,740 | 18.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 55 | 60 | $21,960 | $5,691 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $20,597 | $5,289 | 25.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 242 | 252 | $19,656 | $5,148 | 26.2% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2023 | 86 | 90 | $16,920 | $4,610 | 27.2% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 38 | 39 | $20,711 | $4,410 | 21.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 26 | $12,948 | $3,535 | 27.3% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 115 | 125 | $52,000 | $3,180 | 6.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 89 | 95 | $10,640 | $2,866 | 26.9% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 37 | 38 | $10,336 | $2,803 | 27.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 27 | $9,207 | $2,426 | 26.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 70 | 75 | $7,275 | $1,918 | 26.4% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 43 | 43 | $21,520 | $1,764 | 8.2% |
| 31626 | Placement of radiation therapy markers into lung airways using an endoscope | Facility | 2023 | 22 | 22 | $12,232 | $1,660 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 23 | $5,980 | $1,531 | 25.6% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 13 | 13 | $4,810 | $1,293 | 26.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 18 | $4,680 | $1,289 | 27.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,476 | $1,223 | 27.3% |
About Dr. Jiten Patel, MD
Dr. Jiten Patel, MD is a Pulmonary Disease healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1689895211.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jiten Patel, MD has received a total of $279,386 in payments from pharmaceutical and medical device companies, with $38,659 received in 2024. These payments were reported across 685 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($230,246).
As a Medicare-enrolled provider, Patel has provided services to 8,560 Medicare beneficiaries, totaling 9,036 services with total Medicare billing of $575,745. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine, Internal Medicine
- Location Spokane, WA
- Active Since 05/01/2007
- Last Updated 07/18/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1689895211
Products in Payments
- OFEV (Drug) $88,088
- UPTRAVI (Drug) $23,260
- Adempas (Drug) $9,331
- Da Vinci Surgical System (Device) $6,368
- SuperDimension (Device) $4,788
- SPIRIVA RESPIMAT (Drug) $1,789
- GENERAL - THERAPIES (Device) $1,463
- Pulmonx Endobronchial Valve EBV (Device) $1,169
- TRELEGY ELLIPTA (Drug) $877.39
- TYVASO (Drug) $606.82
- SMARTVEST (Device) $601.23
- DUPIXENT (Biological) $538.53
- OPSUMIT (Drug) $497.03
- BREZTRI (Drug) $478.41
- STIOLTO RESPIMAT (Drug) $331.50
- NUCALA (Biological) $327.00
- TEZSPIRE (Biological) $311.22
- Prolastin-C Liquid (Biological) $299.40
- SYMBICORT (Drug) $241.80
- FASENRA (Biological) $198.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Spokane
Griffith Liang, Md, MD
Pulmonary Disease — Payments: $10,823
Pulmonary Disease $10,823
Benjamin Arthurs, M.d, M.D
Pulmonary Disease — Payments: $7,637
Pulmonary Disease $7,637
Dr. Jeffrey Elmer, M.d, M.D
Pulmonary Disease — Payments: $3,051
Pulmonary Disease $3,051
Dr. Allison Lambert, M.d., M.h.s, M.D., M.H.S
Pulmonary Disease — Payments: $1,119
Pulmonary Disease $1,119
Scot Bradley, Md, MD
Pulmonary Disease
Pulmonary Disease
Dr. Lawrence Klock, Md, MD
Pulmonary Disease
Pulmonary Disease